Showing 91-100 of 1692 results for "".
Epilepsy Essentials: Novel Interictal Biomarkers for Delineating the Epileptogenic Zone in Children With Drug-Resistant Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-novel-interictal-biomarkers-for-delineating-the-epileptogenic-zone-in-children-with-drug-resistant-epilepsy/32147/Novel interictal biomarkers of epilepsy are able to identify the epileptogenic zone with precision and predict surgical outcome in children with drug-resistant epilepsy.In-Focus: Charting a New Course to Seizure Freedom
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/in-focus-charting-a-new-course-to-seizure-freedom/30315/- Sleep Aids: A Primer for Insomnia Treatmenthttps://practicalneurology.com/diseases-diagnoses/sleep/PN0606SleepAids-pdf/31308/Advancements in Insomnia Treatment: Integrating Behavioral and Pharmacological ApproachesInsomnia remains one of the most prevalent sleep disorders affecting millions of adults worldwide, often leading to significant daytime impairment and reduced quality of life. Despite its commonality, many indiv
Women & Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/women-epilepsy/31589/Biology unique to female individuals with epilepsy affects disease management significantly.- Disease-Modifying Therapies for Alzheimer's: New Drugs on the Horizonhttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn0508-ad-fea-pdf/31021/Advancements in Disease-Modifying Therapies for Alzheimer’s DiseaseAlzheimer’s disease (AD) currently impacts approximately 26.6 million individuals globally, with nearly five million cases in the United States. Projections indicate a potential 400% rise by mid-century, underscoring the urgent need
Calcitonin Gene-Related Peptide, Monoclonal Antibodies, and Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/calcitonin-gene-related-peptide-monoclonal-antibodies-and-migraine/30404/The recent development of monoclonal antibodies for the treatment of migraine may have a significant impact on the field and mark a new chapter in patient care.Online Bonus: Opioid Dependence: Misperceptions Abound, but Physicians Can Help
https://practicalneurology.com/diseases-diagnoses/headache-pain/opioid-dependence-misperceptions-abound-but-physicians-can-help/30721/Teleneurology for Cognitive Care
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/teleneurology-for-cognitive-care/31671/Modified workflow and adapted examinations for teleneurology can aid earlier diagnosis and treatment for most cognitive disorders.Access to Newer AEDs and Specialists are Key to Seizure Control
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/access-to-newer-aeds-and-specialists-are-key-to-seizure-control/30541/A new report shows that some patients still lack access to care resources.Point/Counterpoint: Food and Drug Administration Multiple Sclerosis Categorization Changes
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pointcounterpoint-food-and-drug-administration-multiple-sclerosis-categorization-changes/31633/Are the changes a step forward or a step back?